Navigation Links
VWR Acquires EPL Archives, Inc.

RADNOR, Pa., March 22, 2017 /PRNewswire/ -- VWR (NASDAQ: VWR), the leading global independent provider of product and service solutions to laboratory and production customers, announced today that it has acquired EPL Archives, Inc., an international biorepository services organization that supports customers across the entire regulated product research, development and commercialization lifecycle by providing archive sample, document storage and ancillary services. EPL Archives is widely recognized and respected by its customers for consistently delivering high-quality, responsive and compliant professional material management services.

"EPL Archives is a well-known and trusted partner to the majority of the world's largest pharmaceutical customers, including many existing VWR customers," said Manuel Brocke-Benz, President and CEO of VWR. "Their portfolio of services will greatly complement VWR's current service offering, as a part of VWRCATALYST, allowing us to better serve our customers in achieving their goals by ensuring compliant storage of research, manufacturing and clinical trial materials."

Founded in 1978, EPL Archives has several locations in Virginia, U.S. and Carros, France. EPL Archives operates biostorage facilities totaling over 190,000 square feet of storage space including temperature controlled, humidity controlled and ambient storage that are compliant with applicable GLP, GCP and GMP regulations. Services include non-clinical archiving, clinical biorepository and bio banking, regulated data management, manufacturing material storage, and specialized logistics and support services.

Financial details of this acquisition remain confidential.

About VWR

VWR (NASDAQ:  VWR), headquartered in Radnor, Pennsylvania, is the leading global independent provider of product and service solutions to laboratory and production customers. With sales in excess of $4.5 billion in 2016, VWR enables science for customers in the pharmaceutical, biotechnology, industrial, education, government and healthcare industries. With more than 160 years of experience, VWR has cultivated a value proposition delivering product choice, operational excellence and differentiated services to improve our customers' productivity from research to production. VWR's differentiated services provide innovative, flexible and customized solutions from scientific research services to custom-manufactured chemical blends. Our dedicated team of more than 10,200 associates is focused on supporting scientists, medical professionals and production engineers to achieve their goals.

For more information on VWR, please visit

Media Contact:
Valerie Collado
Director, Corporate Communications
VWR International, LLC

Investor Contact:
John Sweeney, CFA
VP, Investor Relations
VWR Corporation
Phone: +610.386.1483


To view the original version on PR Newswire, visit:

Copyright©2017 PR Newswire.
All rights reserved

Related biology technology :

1. Aviva Systems Biology Acquires GenWay Biotech
2. Kernel Acquires KRS to Build Next-Generation Neural Interfaces
3. Ginkgo Bioworks Acquires Leading Synthetic DNA Provider Gen9
4. WuXi AppTec Acquires Biology Focused R&D Service Leader HD Biosciences
5. Pall ForteBio Acquires the Pioneer SPR Product Line from SensiQ Technologies to Expand Its Label-Free Interaction Analysis Portfolio
6. Invitae acquires patient-centered data company AltaVoice, creating new offerings to advance research and access to care for patients with inherited and rare diseases
7. Neogen acquires Brazil-based Rogama
8. Vigene Biosciences Acquires the cGMP Manufacturing Facility and Assets of Omnia Biosciences
9. VetStem Biopharma Acquires 24 New Adipose Stem Cell Patents
10. Proove Biosciences Acquires Algynomics, Inc.
11. CallTower Acquires ConnectSolutions’ Microsoft Skype for Business Assets
Post Your Comments:
(Date:10/11/2017)... ... October 11, 2017 , ... Singh ... orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of ... SBT-100 is able to cross the cell membrane and bind intracellular STAT3 and ...
(Date:10/10/2017)... ... October 10, 2017 , ... For the second time in ... STEM Mentoring Award. Representatives of the FirstHand program travelled to Washington, D.C. Tuesday, ... , US2020’s mission is to change the trajectory of STEM education in America ...
(Date:10/10/2017)... SomaGenics announced the receipt of a Phase ... (Single Cell), expected to be the first commercially available ... from single cells using NGS methods. The NIH,s recent ... development of approaches to analyze the heterogeneity of cell ... for measuring levels of mRNAs in individual cells have ...
(Date:10/9/2017)... SAN DIEGO , Oct. 9, 2017 /PRNewswire/ ... a biological mechanism by which its ProCell stem ... of critical limb ischemia.  The Company, demonstrated that ... the amount of limbs saved as compared to ... of the molecule HGF resulted in reduction of ...
Breaking Biology Technology:
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC , ... that the United States Patent and Trademark Office (USPTO) ... covers the linking of an iris image with a ... and represents the company,s 45 th issued patent. ... is very timely given the multi-modal biometric capabilities that ...
(Date:3/30/2017)... ANGELES , March 30, 2017  On April ... Hack the Genome hackathon at Microsoft,s ... exciting two-day competition will focus on developing health and ... Hack the Genome is the ... been tremendous. The world,s largest companies in the genomics, ...
(Date:3/30/2017)... Trends, opportunities and forecast in this market ... (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, vein ... use industry (government and law enforcement, commercial and retail, ... others), and by region ( North America ... Pacific , and the Rest of the World) ...
Breaking Biology News(10 mins):